Market research firm Kalorama Information estimates the consumer market for genetic health testing could triple by 2022. 23andMe's Director of Product Science Shirley Wu explains how the testing company is differentiating itself in this growing market. "We are the only direct-to-consumer genetic testing company that provides health related information," said Wu. "We believe that everyone has the right to their own DNA information. It's information about you--you should know it if you want to know it." 23andMe CEO Anne Wojcicki has been outspoken about the company's efforts to maintain a gender-equal workforce. "It's been really great to be a part of a company like that where from the beginning we had really strong female leaders who set the vision for the company," says Wu. "There's never been a question of can women hold their own."

Share:
More In Technology
TikTok to Test Paid Subscription Model on Its Platform
TikTok recently announced that it is testing a paid subscription model. The news comes days after Instagram publicized a similar service. TikTok has made $2.3 billion from in-app purchases, but mostly through tips, in 2021, showing that its users may be open to spending money on the platform.
Why Netflix Stock Is Taking a Beating Despite Q4 Earnings Beat
Netflix beat its earnings projections for Q4 — but the stock still plummeted as the streaming pioneer cut back on its forecast for future subscribers. Michael Robinson, the chief technology strategist at Money Map Press, joined Cheddar to discuss the report and what's driving the downward pressure on its shares. "It's the growth is really what's worrying people," he said. "'A' we have slowing economic growth, and 'B' we've got slowing growth for this company, as 'C' we have an increase in competition."
Load More